Logo Image
News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtablesShorts
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

BRAYDEN SCHINDELL

Advertisement

Articles by BRAYDEN SCHINDELL

What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures

ByBRAYDEN SCHINDELL,JASON KINDRACHUK, PHD,KRUTIKA KUPPALLI, MD
April 14th 2020

How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?

Advertisement

Latest Updated Articles

  • What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures
    What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental Countermeasures

    April 14th 2020



Advertisement
Advertisement

Trending on Contagion Live

1

Cyclosporiasis Case Count Tops 7000 as Lettuce Probe Continues

2

Once-Weekly Islatravir/Lenacapavir Meets Phase 3 Primary End Point

3

The Latest on the Cyclosporiasis Outbreak: An FDA False Positive Test, and What Treatment Looks Like

4

FDA Authorizes First Multiplex PCR Assay for HSV, VZV, and Mpox Skin Lesions

5

Researching Repurposed Medications for Long COVID

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us